Skip to content
ppharmaranks
Menu
Class IIOngoing

Moxifloxacin 5mg/ml recall

FDA recall D-0362-2024 · initiated Feb 20, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 6, 2024How we research

Denver Solutions, LLC DBA Leiters Health recalled Moxifloxacin 5mg/ml in Feb 2024 — an FDA Class II recall (D-0362-2024) because Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.

Quantity recalled: 10,020 vials

Details

Product
Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42
Recalling company
Denver Solutions, LLC DBA Leiters Health
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 20, 2024
FDA report date
Mar 6, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Moxifloxacin 5mg/ml recalled?
Denver Solutions, LLC DBA Leiters Health recalled Moxifloxacin 5mg/ml in Feb 2024 — an FDA Class II recall (D-0362-2024) because Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Moxifloxacin 5mg/ml recalled?
Per the FDA enforcement record, the reason for recall D-0362-2024 was: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Is a recalled Moxifloxacin 5mg/ml dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Moxifloxacin 5mg/ml are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0362-2024.

Source: openFDA Drug Enforcement record D-0362-2024

← All drug recalls